HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

SANORG 34006

a sulfated pentasaccharide obtained by chemical synthesis; structure in first source
Also Known As:
SANORG-34006; SR 34006; SR-34006; SR34006
Networked: 7 relevant articles (1 outcomes, 5 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Lip, Gregory Y H: 5 articles (11/2015 - 07/2011)
2. Lane, Deirdre A: 4 articles (09/2015 - 07/2011)
3. Senoo, Keitaro: 2 articles (11/2015 - 09/2015)
4. Büller, Harry R: 2 articles (09/2015 - 07/2011)
5. Apostolakis, Stavros: 2 articles (12/2013 - 08/2012)
6. Buller, Harry: 2 articles (12/2013 - 08/2012)
7. Kotecha, Dipak: 1 article (09/2015)
8. Guo, Yutao: 1 article (08/2012)
9. Kamphuisen, Pieter W: 1 article (07/2011)
10. Minini, Pascal: 1 article (07/2011)

Related Diseases

1. Thrombosis (Thrombus)
2. Atrial Fibrillation
11/01/2015 - "We investigated the incidence of adverse outcomes between tertiles of age groups (age, <67 [n=722]; age, 67-74 [n=747]; and age, ≥75 [n=824]) in 2293 patients with atrial fibrillation participating in warfarin arm in the AMADEUS (Evaluating the Use of SR34006 Compared to Warfarin or Acenocoumarol in Patients With Atrial Fibrillation) trial. "
09/01/2015 - "We investigated the prognosis of anticoagulated patients with permanent AF and nonpermanent AF according to preexisting heart failure in the AMADEUS (Evaluating the Use of SR34006 Compared to Warfarin or Acenocoumarol in Patients With Atrial Fibrillation) trial. "
08/28/2012 - "Performance of the HEMORR(2)HAGES, ATRIA, and HAS-BLED bleeding risk-prediction scores in patients with atrial fibrillation undergoing anticoagulation: the AMADEUS (evaluating the use of SR34006 compared to warfarin or acenocoumarol in patients with atrial fibrillation) study."
12/01/2013 - "We used data from the vitamin K antagonist (VKA) arm (n = 2,293; 65% men; mean age 70 ± 9 years) of the AMADEUS (Evaluating the Use of SR34006 Compared to Warfarin or Acenocoumarol in Patients With Atrial Fibrillation) trial, which was a multicenter, randomized, open-label noninferiority study that compared fixed-dose idraparinux with VKA in patients with AF. "
08/28/2012 - "We analyzed the dataset from the AMADEUS (Evaluating the Use of SR34006 Compared to Warfarin or Acenocoumarol in Patients With Atrial Fibrillation) trial, a multicenter, randomized, open-label noninferiority study that compared fixed-dose idraparinux with adjustable-dose oral vitamin K antagonist therapy in patients with AF. "
3. Hemorrhage
4. Heart Failure
5. Venous Thrombosis (Deep-Vein Thrombosis)

Related Drugs and Biologics

1. Fibrin
2. Warfarin (Coumadin)
3. Acenocoumarol
4. Vitamin K
5. idraparinux
6. Heparin (Liquaemin)
7. Enoxaparin (Lovenox)
8. Org 36764
9. ferric chloride